Volume 44, Issue 5, Pages (May 2006)

Slides:



Advertisements
Similar presentations
EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Advertisements

Omega 3 – Omega 6: What is right for the liver? Ashraf Mohammad El-Badry, Rolf Graf, Pierre-Alain Clavien Journal of Hepatology Volume 47, Issue 5, Pages.
Volume 66, Issue 4, Pages (April 2017)
Volume 63, Issue 1, Pages (July 2015)
Volume 67, Issue 2, Pages (August 2017)
Volume 46, Issue 3, Pages (March 2007)
Kirsten Boonstra, Ulrich Beuers, Cyriel Y. Ponsioen 
Inflammasomes in liver diseases
Primary biliary cirrhosis developing in a patient with Crohn's disease during the course of infliximab treatment: The first case in the literature  Gurhan.
The role of Epstein–Barr virus in acute and chronic hepatitis
Volume 51, Issue 3, Pages (September 2009)
Hepatic CD141+IFNλ+ DC subset: One against all?
Anatoliy I. Masyuk, Tatyana V. Masyuk, Nicholas F. LaRusso 
Volume 61, Issue 6, Pages (December 2014)
Halis Simsek, Ali Shorbagi, Yasemin Balaban, Gonca Tatar 
Machine perfusion in liver transplantation as a tool to prevent non-anastomotic biliary strictures: Rationale, current evidence and future directions 
Reactive oxygen species in the normal and acutely injured liver
Cédric Coulouarn, Bruno Clément  Journal of Hepatology 
Matthew T. Kitson, Stuart K. Roberts  Journal of Hepatology 
The management of childhood liver diseases in adulthood
Volume 53, Issue 5, Pages (November 2010)
Immigration and viral hepatitis
Volume 67, Issue 2, Pages (August 2017)
Primovist, Eovist: What to expect?
The evidence supports a viral aetiology for primary biliary cirrhosis
Living donor liver transplantation: is the hype over?
Nicolas Moniaux, Jamila Faivre  Journal of Hepatology 
The role of Epstein–Barr virus in acute and chronic hepatitis
Volume 63, Issue 1, Pages (July 2015)
Volume 44, Issue 6, Pages (June 2006)
Maya Srivastava, Antonio Perez–Atayde, Maureen M. Jonas 
Mauro Bernardi, Stefano Gitto, Maurizio Biselli  Journal of Hepatology 
Volume 66, Issue 1, Pages (January 2017)
Hepatitis C core protein – The “core” of immune deception?
Burcin Ekser, Eric Lagasse  Journal of Hepatology 
Marc van der Valk, Hans L. Zaaijer, Arnon P. Kater, Janke Schinkel 
Volume 42, Issue 2, Pages (February 2005)
What is the long-term outcome of the liver allograft?
Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control study  Gyuri Kim, Suk-Yong Jang, Chung.
Aloysious D. Aravinthan, Graeme J.M. Alexander  Journal of Hepatology 
Why men are at higher risk for hepatocellular carcinoma?
Volume 62, Issue 3, Pages (March 2015)
Volume 41, Issue 5, Pages (November 2004)
Volume 59, Issue 1, Pages (July 2013)
Volume 53, Issue 5, Pages (November 2010)
EASL Clinical Practice Guidelines: Wilson’s disease
Roberto de Franchis, Aleksander Krag  Journal of Hepatology 
Volume 57, Issue 5, Pages (November 2012)
Liver stem cells—prospects for clinical use
Portal vein thrombosis, cirrhosis, and liver transplantation
Volume 44, Issue 4, Pages (April 2006)
Immigration and viral hepatitis
The potential of induced pluripotent stem cell derived hepatocytes
Volume 63, Issue 1, Pages (July 2015)
Volume 64, Issue 1, Pages (January 2016)
Primovist, Eovist: What to expect?
The use of hemospray in portal hypertensive bleeding; a case series
Volume 41, Issue 6, Pages (December 2004)
Volume 62, Issue 3, Pages (March 2015)
HCV animal models and liver disease
Volume 60, Issue 1, Pages (January 2014)
Statins: Old drugs as new therapy for liver diseases?
Liver transplantation in children
Ana Lleo, M. Eric Gershwin, Alberto Mantovani, Pietro Invernizzi 
Pathogenesis of cholestatic hepatitis C
The origin of biliary strictures after liver transplantation: Is it the amount of epithelial injury or insufficient regeneration that counts?  Negin Karimian,
Volume 44, Issue 1, Pages (January 2006)
Platelets arrive at the scene of fibrosis……studies
Niya Aleksieva, Stuart J. Forbes  Journal of Hepatology 
Thierry Gustot, Rajiv Jalan  Journal of Hepatology 
Presentation transcript:

Volume 44, Issue 5, Pages 947-955 (May 2006) The finest branches of the biliary tree might induce biliary vascularization necessary for biliary regeneration  Marius C. van den Heuvel, Annette S.H. Gouw, Marcel Boot, Maarten J.H. Slooff, Sibrand Poppema, Koert P. de Jong  Journal of Hepatology  Volume 44, Issue 5, Pages 947-955 (May 2006) DOI: 10.1016/j.jhep.2005.08.011 Copyright © 2005 European Association for the Study of the Liver Terms and Conditions

Fig. 1 Portal tract of a control patient at reperfusion (A), 1-week (B) and 1-year (C). Biliary epithelium is stained in red, endothelium is stained in brown. (A) and (C): normal bile ducts (black arrow) and bile ductules (black arrowheads) with escorting microvasculature. (B): damaged bile duct (black arrow). Bile ductules without escorting microvessels (white arrowheads) are increased. Journal of Hepatology 2006 44, 947-955DOI: (10.1016/j.jhep.2005.08.011) Copyright © 2005 European Association for the Study of the Liver Terms and Conditions

Fig. 2 Portal tract of a CR patient at reperfusion (A), 1-month (B) and 1-year (C). Biliary epithelium is stained in red, endothelium is stained in brown. (A): normal bile ducts (black arrow) and bile ductules (black arrowheads) with escorting microvasculature. (B): bile duct (white arrow) and only two bile ductules (white arrowheads) without escorting microvasculature. (C): damaged bile ducts without escorting microvessels (white arrows). Absence of bile ductules. Journal of Hepatology 2006 44, 947-955DOI: (10.1016/j.jhep.2005.08.011) Copyright © 2005 European Association for the Study of the Liver Terms and Conditions

Fig. 3 Portal tract of a control patient at reperfusion (A) and 1-week (B). (A): bile duct (black arrow) and bile ductules (black arrowheads) showing a weak positive staining for VEGF-A. (B): bile duct (black arrow) and bile ductules (black arrowheads) in the control group at 1-week showing strong positive staining for VEGF-A In both figures hepatocytes show a weak membranous expression. Journal of Hepatology 2006 44, 947-955DOI: (10.1016/j.jhep.2005.08.011) Copyright © 2005 European Association for the Study of the Liver Terms and Conditions

Fig. 4 Boxplots showing numbers of bile ducts with capillaries (A), without capillaries (B) and total number of bile ducts (C) per portal tract at reperfusion (RPB), 1-week (1-W), 1-month (1-M) and 1-year (1-Y) in CR and the controls. (A): *, lower in CR at 1-year (reperfusion P=0.012; 1-week P=0.021). Journal of Hepatology 2006 44, 947-955DOI: (10.1016/j.jhep.2005.08.011) Copyright © 2005 European Association for the Study of the Liver Terms and Conditions

Fig. 5 Boxplots showing numbers of bile ductules with microvessels (A), without microvessels (B) and the total number of bile ductules (C) per portal tract at reperfusion (RPB), 1-week (1-W), 1-month (1-M) and 1-year (1-Y) in CR and the controls. (A): *, lower in CR at 1-year (reperfusion P=0.004; 1-week P=0.005; 1-month P=0.028); #, higher in controls at 1-month (reperfusion P=0.049; 1-year P=0.007). (B): #, higher in controls at 1-week (reperfusion P=0.003; 1-month P=0.036; 1-year P=0.001); ##, higher in controls at 1-month (reperfusion P=0.011; 1-year P=0.002). (C): *, lower in CR at 1-year (reperfusion P=0.006; 1-week P=0.007; 1-month P=0.015); #, higher in controls at 1-week (reperfusion P=0.026; 1-year P=0.008); ##, higher in controls at 1-month (reperfusion P=0.017; 1-year P=0.003). Journal of Hepatology 2006 44, 947-955DOI: (10.1016/j.jhep.2005.08.011) Copyright © 2005 European Association for the Study of the Liver Terms and Conditions

Fig. 6 Boxplots showing numbers of extraportal biliary cells with microvessels (A), without microvessels (B) and the total number of extraportal biliary cells (C) per portal tract at reperfusion (RPB), 1-week (1-W), 1-month (1-M) and 1-year (1-Y) in CR and the controls. (A): *, higher in CR at reperfusion (1-week P=0.01; 1-year P=0.003); **, higher in CR at 1-month (1-year P=0.038). (C): *, higher in CR at reperfusion (1-week P=0.05; 1-year P=0.006); **, higher in CR at 1-month (1-year P=0.041). Journal of Hepatology 2006 44, 947-955DOI: (10.1016/j.jhep.2005.08.011) Copyright © 2005 European Association for the Study of the Liver Terms and Conditions

Fig. 7 Boxplots showing the total portal (A) and extraportal (B) microvascular compartment. (A): #, lower in controls at 1-week (reperfusion P=0.006); ##, higher in controls at 1-month (reperfusion P=0.003; 1-week P=0.03); ###, lower in controls at 1-year (1-month P=0.02). (B): *, higher in CR at reperfusion (1-week P=0.034; 1-month P=0.005); #, higher in controls at reperfusion (1-week P=0.002; 1-month P<0.001); ##, higher in controls at 1-year (1-month P=0.007). Journal of Hepatology 2006 44, 947-955DOI: (10.1016/j.jhep.2005.08.011) Copyright © 2005 European Association for the Study of the Liver Terms and Conditions

Fig. 8 Line graphs representing the median values of the counted portal structures with exception of bile ducts per portal tract in time. Journal of Hepatology 2006 44, 947-955DOI: (10.1016/j.jhep.2005.08.011) Copyright © 2005 European Association for the Study of the Liver Terms and Conditions

Fig. 9 Line graphs representing the median values of the extraportal counted structures per portal tract in time. Journal of Hepatology 2006 44, 947-955DOI: (10.1016/j.jhep.2005.08.011) Copyright © 2005 European Association for the Study of the Liver Terms and Conditions